{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:45:34Z","timestamp":1793828734060,"version":"4.6.1"},"reference-count":30,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1756,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1111\/j.1365-2893.2009.01250.x","type":"journal-article","created":{"date-parts":[[2010,1,13]],"date-time":"2010-01-13T08:28:09Z","timestamp":1263371289000},"page":"839-844","source":"Crossref","is-referenced-by-count":91,"title":["Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals"],"prefix":"10.1111","volume":"17","author":[{"given":"C.","family":"Treloar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Newland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Rance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hopwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,10]]},"reference":[{"issue":"4","key":"10.1111\/j.1365-2893.2009.01250.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1081\/ADA-200037544","article-title":"Outpatient drug treatment program directors\u2019 hepatitis C-related beliefs and their relationship to the provision of HCV services","volume":"30","author":"Astone","year":"2004","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"10.1111\/j.1365-2893.2009.01250.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/02791072.2006.10399849","article-title":"Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programs","volume":"38","author":"Munoz-Plaza","year":"2006","journal-title":"J Psychoactive Drugs"},{"issue":"11","key":"10.1111\/j.1365-2893.2009.01250.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.5694\/j.1326-5377.2006.tb00380.x","article-title":"National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia","volume":"184","author":"Winstock","year":"2006","journal-title":"Med J Aust"},{"issue":"4","key":"10.1111\/j.1365-2893.2009.01250.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1353\/hpu.2004.0075","article-title":"Provision of on-site medical care to patients with hepatitis C in drug treatment units","volume":"15","author":"Vassilev","year":"2004","journal-title":"J Health Care Poor Underserved"},{"issue":"4","key":"10.1111\/j.1365-2893.2009.01250.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0740-5472(03)00037-0","article-title":"Gaps in the drug-free and methadone treatment program response to hepatitis C","volume":"24","author":"Strauss","year":"2003","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"10.1111\/j.1365-2893.2009.01250.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0740-5472(01)00213-6","article-title":"A nationwide survey of hepatitis C services provided by drug treatment programs","volume":"22","author":"Strauss","year":"2002","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"10.1111\/j.1365-2893.2009.01250.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2105\/AJPH.92.8.1254","article-title":"Hepatitis C screening and management practices: a survey of drug treatment and syringe exchange programs in New York City","volume":"92","author":"Pratt","year":"2002","journal-title":"Am J Public Health"},{"key":"10.1111\/j.1365-2893.2009.01250.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jsat.2006.12.001","article-title":"Hepatitis C management by addiction medicine physicians: results from a national survey","volume":"33","author":"Litwin","year":"2007","journal-title":"J Subst Abuse Treat"},{"key":"10.1111\/j.1365-2893.2009.01250.x-BIB9|cit9","article-title":"Low uptake of treatment for hepatitis C virus (HCV) infection in a large community-based cohort of illicit drug users in Vancouver","volume":"46","author":"Grebely","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2009.01250.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10900-007-9083-3","article-title":"Limited uptake of hepatitis C treatment among injection drug users","volume":"33","author":"Mehta","year":"2008","journal-title":"J Community Health"},{"key":"10.1111\/j.1365-2893.2009.01250.x-BIB11|cit11","volume-title":"Hepatitis C virus Projections Working Group: Estimates and Projections of the Hepatitis C Virus Epidemic in Australia 2006","author":"Ministerial Advisory Committee on AIDS Sexual Health and Hepatitis, Hepatitis C Sub-Committee","year":"2006"},{"key":"10.1111\/j.1365-2893.2009.01250.x-BIB12|cit12","volume-title":"Australian NSP Survey National Data Report 2004-2008","author":"National Centre in HIV Epidemiology and Clinical Research","year":"2009"},{"issue":"S5","key":"10.1111\/j.1365-2893.2009.01250.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1086\/427446","article-title":"Hepatitis C treatment knowledge, attitudes and barriers among current injecting drug users in Australia","volume":"40","author":"Doab","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1111\/j.1365-2893.2009.01250.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2007.09.008","article-title":"Barriers associated with treatment of hepatitis C virus infection among illicit drug users","volume":"93","author":"Grebely","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1111\/j.1365-2893.2009.01250.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0376-8716(00)00144-7","article-title":"Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment","volume":"61","author":"Stein","year":"2001","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1111\/j.1365-2893.2009.01250.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1360-0443.2008.02188.x","article-title":"Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients","volume":"103","author":"Novick","year":"2008","journal-title":"Addiction"},{"key":"10.1111\/j.1365-2893.2009.01250.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jsat.2008.09.009","article-title":"Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program","volume":"37","author":"Litwin","year":"2009","journal-title":"J Subst Abuse Treat"},{"issue":"5","key":"10.1111\/j.1365-2893.2009.01250.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1467-842X.2006.tb00457.x","article-title":"Now, later or never? Challenges associated with hepatitis C treatment","volume":"30","author":"McNally","year":"2006","journal-title":"Aust N Z J Public Health"},{"key":"10.1111\/j.1365-2893.2009.01250.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.amjmed.2005.05.029","article-title":"What do patients consider when making decisions about treatment for hepatitis C?","volume":"118","author":"Fraenkel","year":"2005","journal-title":"Am J Med"},{"issue":"5","key":"10.1111\/j.1365-2893.2009.01250.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.drugpo.2007.01.010","article-title":"Integrating HCV services for drug users: a model to improve engagement and outcomes","volume":"18","author":"Sylvestre","year":"2007","journal-title":"Int J Drug Policy"},{"issue":"8","key":"10.1111\/j.1365-2893.2009.01250.x-BIB21|cit21","article-title":"The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users","volume":"5","author":"Norman","year":"2008","journal-title":"Harm Reduct J"},{"key":"10.1111\/j.1365-2893.2009.01250.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/600304","article-title":"Hepatitis C treatment for injecting drug users: a review of the available evidence","volume":"49","author":"Hellard","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2893.2009.01250.x-BIB23|cit23","volume-title":"Qualitative Research and Evaluation Methods","author":"Patton","year":"2002"},{"key":"10.1111\/j.1365-2893.2009.01250.x-BIB24|cit24","volume-title":"Health Psychology and Public Health: an Integrative Approach","author":"Winett","year":"1989"},{"issue":"5","key":"10.1111\/j.1365-2893.2009.01250.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.drugpo.2007.02.004","article-title":"The depiction of stigmatization in research about hepatitis C","volume":"18","author":"Paterson","year":"2007","journal-title":"Int J Drug Policy"},{"key":"10.1111\/j.1365-2893.2009.01250.x-BIB26|cit26","volume-title":"Experiences of Hepatitis C and its Management: What Some Patients and Health Professionals Say","author":"Hopwood","year":"2006"},{"key":"10.1111\/j.1365-2893.2009.01250.x-BIB27|cit27","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7517-3-31","article-title":"Therapeutic challenges in hepatitis C-infected injection drug using patients","volume":"3","author":"Cooper","year":"2006","journal-title":"Harm Reduct J"},{"issue":"5","key":"10.1111\/j.1365-2893.2009.01250.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.drugpo.2007.01.007","article-title":"Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study","volume":"18","author":"Nguyen","year":"2007","journal-title":"Int J Drug Policy"},{"issue":"2","key":"10.1111\/j.1365-2893.2009.01250.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2524.2007.00739.x","article-title":"Barriers to accessing generic health and social care services: a qualitative study of injecting drug users","volume":"16","author":"Neale","year":"2008","journal-title":"Health Soc Care Community"},{"key":"10.1111\/j.1365-2893.2009.01250.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1465-3362.2009.00031.x","article-title":"Hepatitis C treatment: increasing treatment uptake needs a critical view [Commentary]","volume":"28","author":"Treloar","year":"2009","journal-title":"Drug Alcohol Rev"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.2009.01250.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2893.2009.01250.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T08:46:57Z","timestamp":1625561217000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.2009.01250.x"}},"subtitle":["Hepatitis C treatment in opiate substitution"],"short-title":[],"issued":{"date-parts":[[2010,11,10]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.2009.01250.x","relation":{},"ISSN":["1352-0504"],"issn-type":[{"value":"1352-0504","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,10]]}}}